Man sitting on a CT scanner

Chronic Traumatic Encephalopathy in the Black Community

12:00pm - July 21, 2022 | Timezone: US/Eastern
Collaborating TTC: Central East MHTTC
Registration Deadline: July 21, 2022
Need more information?
Contact us at [email protected]

This webinar will provide a comprehensive overview of chronic traumatic encephalopathy (CTE) which is a neurodegenerative disease. This diagnosis, which can only be made after death, is associated with brain changes that have mixed features of Alzheimer’s disease and amyotrophic lateral sclerosis. While CTE is thought of as a condition associated with sports, other common causes include domestic abuse, falls, and motor vehicle accidents. The presenter will discuss the epidemiology of traumatic brain injury (TBI), cognitive, behavioral and mood symptoms which accompany TBI, and the course and outcomes of CTE.

Download Flyer


Learning Objectives

  • Describe the epidemiology of TBI and common causes of CTE
  • List the stages of CTE
  • Discuss the impact of TBI on mood, behavior, and cognitive functioning
  • Specify the association between CTE, suicide, and violence


Who Should Attend?
Healthcare professionals, peer advocates, community activists, policymakers, lay public


Benjamin RoyBenjamin Roy, MD is the immediate past president of the Black Psychiatrists of America. He received his medical degree from Howard University College of Medicine and served his internship in internal medicine at Harlem Hospital and a psychiatry residency at St. Vincent’s Hospital, both in New York, NY. He then completed a clinical fellowship in neuropharmacology at the National Institute of Mental Health and in neuroimmunology at the National Institute of Neurological, Communicative Disorders and Stroke, NIH, both in Bethesda, MD. He is a diplomate of the American Board of Psychiatry and Neurology and Fellow of the American Psychiatric Association. Dr. Roy discovered human antibodies for endorphins and the opiate receptor in patients with psychiatric disorders and holds two US patents on methods of detecting certain antibodies in human body fluids. He has participated in numerous phase 2-4 clinical trials in neuropharmacology and neuroimmunology. He exposed the purpose of the Tuskegee Syphilis Experiment to develop syphilis diagnostic tests that were patented and commercialized.


Certificates of attendance are available upon request

  • Requirement: Viewing 50% (30 minutes) or more of the live webinar 
  • Emailed to attendees within 30 days after the webinar date